RU2009126450A - Штамм tbmi12 mscl p737 спорогенного микроорганизма bacillus smithii и применение его эндоспор в качестве пробиотика или пищевой добавки и пробиотическая композиция - Google Patents
Штамм tbmi12 mscl p737 спорогенного микроорганизма bacillus smithii и применение его эндоспор в качестве пробиотика или пищевой добавки и пробиотическая композиция Download PDFInfo
- Publication number
- RU2009126450A RU2009126450A RU2009126450/10A RU2009126450A RU2009126450A RU 2009126450 A RU2009126450 A RU 2009126450A RU 2009126450/10 A RU2009126450/10 A RU 2009126450/10A RU 2009126450 A RU2009126450 A RU 2009126450A RU 2009126450 A RU2009126450 A RU 2009126450A
- Authority
- RU
- Russia
- Prior art keywords
- probiotic
- strain
- composition according
- food additive
- microorganism
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Fodder In General (AREA)
Abstract
1. Штамм микроорганизма Bacillus smithii TBMI12 MSCL P737. ! 2. Применение микроорганизма по п.1 в качестве пищевой и/или кормовой добавки. ! 3. Применение микроорганизма по п.1 в качестве компонента пробиотических композиций. ! 4. Композиция, содержащая микроорганизм по п.1. ! 5. Композиция по п.4, дополнительно содержащая один или более антибиотик. ! 6. Композиция по п.5, причем упомянутый антибиотик является метронидазолом. ! 7. Композиция по п.4 для применения в качестве пробиотика с целью колонизации желудочно-кишечного тракта. ! 8. Композиция по п.4 для применения в качестве пробиотика с целью профилактики бактериальных инфекций желудочно-кишечного тракта. ! 9. Композиция по п.4 для применения в качестве пробиотика с целью стимуляции иммунной системы. ! 10. Композиция по п.4 для наружного применения в качестве антибактериального средства. ! 11. Композиция по п.4 для применения в качестве медицинского средства, позволяющего снизить или устранить побочное действие при лечении антибиотиками.
Claims (11)
1. Штамм микроорганизма Bacillus smithii TBMI12 MSCL P737.
2. Применение микроорганизма по п.1 в качестве пищевой и/или кормовой добавки.
3. Применение микроорганизма по п.1 в качестве компонента пробиотических композиций.
4. Композиция, содержащая микроорганизм по п.1.
5. Композиция по п.4, дополнительно содержащая один или более антибиотик.
6. Композиция по п.5, причем упомянутый антибиотик является метронидазолом.
7. Композиция по п.4 для применения в качестве пробиотика с целью колонизации желудочно-кишечного тракта.
8. Композиция по п.4 для применения в качестве пробиотика с целью профилактики бактериальных инфекций желудочно-кишечного тракта.
9. Композиция по п.4 для применения в качестве пробиотика с целью стимуляции иммунной системы.
10. Композиция по п.4 для наружного применения в качестве антибактериального средства.
11. Композиция по п.4 для применения в качестве медицинского средства, позволяющего снизить или устранить побочное действие при лечении антибиотиками.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EEP200600038A EE05459B1 (et) | 2006-12-08 | 2006-12-08 | Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon |
| EEP200600038 | 2006-12-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2009126450A true RU2009126450A (ru) | 2011-01-20 |
| RU2439145C2 RU2439145C2 (ru) | 2012-01-10 |
Family
ID=38921740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009126450/10A RU2439145C2 (ru) | 2006-12-08 | 2007-10-08 | Штамм микроорганизма bacillus smithii tbmi12 mscl p737 и применение его в качестве пищевой или кормовой добавки, или компонента пробиотической композиции и пробиотическая композиция |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2101796B1 (ru) |
| AT (1) | ATE533499T1 (ru) |
| DK (1) | DK2101796T3 (ru) |
| EE (1) | EE05459B1 (ru) |
| ES (1) | ES2374082T3 (ru) |
| RU (1) | RU2439145C2 (ru) |
| UA (1) | UA99450C2 (ru) |
| WO (1) | WO2008067827A1 (ru) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2509149C1 (ru) * | 2012-08-31 | 2014-03-10 | Общество с ограниченной ответственностью "НОВА" | ШТАММ Bacillus subtilis subsp. Subtilis ВКМ В-2711D, ОБЛАДАЮЩИЙ ВЫРАЖЕННЫМ АНТАГОНИЗМОМ ПО ОТНОШЕНИЮ К Escherichia coli, Salmonella typhi, Staphylococcus aureus, Listeria monocytogenes И РЕЗИСТЕНТНОСТЬЮ К СТРЕПТОМИЦИНУ И ТЕТРАЦИКЛИНУ |
| US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| BR112015011933A8 (pt) * | 2012-11-23 | 2022-09-20 | Seres Therapeutics Inc | Composições bacterianas sinérgicas e métodos de produção e uso das mesmas |
| EP2951283A4 (en) | 2013-02-04 | 2017-01-25 | Seres Therapeutics, Inc. | Compositions and methods |
| CN110917220A (zh) | 2013-02-04 | 2020-03-27 | 赛里斯治疗公司 | 治疗组合物及其使用方法 |
| EP2967077A4 (en) | 2013-03-15 | 2016-09-14 | Seres Therapeutics Inc | MICROBIAL COMPOSITIONS AND ASSOCIATED METHODS BASED ON A NETWORK |
| CN116370507A (zh) | 2013-11-25 | 2023-07-04 | 赛里斯治疗公司 | 协同细菌组合物以及其制造方法和用途 |
| US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
| RS57471B1 (sr) | 2015-12-17 | 2018-09-28 | Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerzitet U Beogradu | Nova probiotička starter kultura za humanu i animalnu primenu |
| JP2020530840A (ja) | 2017-08-14 | 2020-10-29 | セレス セラピューティクス インコーポレイテッド | 胆汁うっ滞性疾患を治療するための組成物及び方法 |
| CN114410514B (zh) * | 2021-12-31 | 2024-04-02 | 上海新溢生物科技工程研究中心(有限合伙) | 斯密氏芽孢杆菌及其用途 |
-
2006
- 2006-12-08 EE EEP200600038A patent/EE05459B1/xx not_active IP Right Cessation
-
2007
- 2007-10-08 RU RU2009126450/10A patent/RU2439145C2/ru not_active IP Right Cessation
- 2007-10-08 WO PCT/EE2007/000021 patent/WO2008067827A1/en active Application Filing
- 2007-10-08 AT AT07817985T patent/ATE533499T1/de active
- 2007-10-08 DK DK07817985.0T patent/DK2101796T3/da active
- 2007-10-08 EP EP07817985A patent/EP2101796B1/en not_active Not-in-force
- 2007-10-08 ES ES07817985T patent/ES2374082T3/es active Active
- 2007-10-08 UA UAA200906956A patent/UA99450C2/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK2101796T3 (da) | 2012-02-13 |
| WO2008067827A1 (en) | 2008-06-12 |
| RU2439145C2 (ru) | 2012-01-10 |
| UA99450C2 (ru) | 2012-08-27 |
| EP2101796B1 (en) | 2011-11-16 |
| EP2101796A1 (en) | 2009-09-23 |
| ES2374082T3 (es) | 2012-02-13 |
| ATE533499T1 (de) | 2011-12-15 |
| EE200600038A (et) | 2008-08-15 |
| EE05459B1 (et) | 2011-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2009126450A (ru) | Штамм tbmi12 mscl p737 спорогенного микроорганизма bacillus smithii и применение его эндоспор в качестве пробиотика или пищевой добавки и пробиотическая композиция | |
| Anderson et al. | Enterococcus faecalis from food, clinical specimens, and oral sites: prevalence of virulence factors in association with biofilm formation | |
| Agyare et al. | Antibiotic use in poultry production and its effects on bacterial resistance | |
| Cammarota et al. | biofilm formation by H elicobacter pylori as a target for eradication of resistant infection | |
| ATE526962T1 (de) | Biotherapeutische zusammensetzung mit probiotischen escherichia coli und metronidazol und ihre verwendungen | |
| JP2015213501A5 (ru) | ||
| MX2009012694A (es) | Composicones y metodos utiles para modular la inmunidad, mejorar la eficacia de vacunas, disminuir la morbilidad asociada con infecciones cronicas por fhv-1, y prevenir o tratar la conjuntivitis. | |
| WO2018208985A3 (en) | Antibacterial compounds | |
| WO2000010582A3 (en) | Probiotic, lactic acid-producing bacteria and uses thereof | |
| EP2561880A3 (en) | Lactic acid bacteria as probiotic strains and compositions containing same | |
| TW200738249A (en) | Harmful bacterium control agent containing bacillus thuringiensis | |
| WO2009040445A3 (en) | Arabinoxylo-oligosaccharides useful against gastrointestinal infections | |
| Goncuoglu et al. | Antibiotic resistance of Escherichia coli O157: H7 isolated from cattle and sheep | |
| WO2005112976A3 (en) | Probiotic compounds from lactobacillus gg and uses therefor | |
| PH12019500360A1 (en) | Antibiotic compounds | |
| MX2021003084A (es) | Compuestos antibacterianos. | |
| DK1624762T3 (da) | Probiotisk præparat med mindst to mælkesyrebakteriestammer som er i stand til kolonisere mavetarmkanalen, i kombination med at de besidder overlevelsesegenskab, tarmbindende egenskab, en infektionsbeskyttelsesegenskab og en fiberfermenterende egenskab | |
| Srinu et al. | Evaluation of different lactic acid bacterial strains for probiotic characteristics. | |
| Bell et al. | Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008) | |
| EP2124976A4 (en) | WAKE-INHIBITION AND ELIMINATION OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS BY MILKY ACID BACTERIA | |
| RU2009105957A (ru) | Способ приготовления силоса | |
| Laal-Kargar et al. | Antibacterial and antibiofilm effects of synbiotics against multidrug-resistant bacteria: acinetobacter baumannii and Enterococcus faecalis | |
| Sharma et al. | Aerobic bacteriological profile of skin and soft tissue infections (SSTIs) and its antimicrobial susceptibility pattern at MB Govt. Hospital in Udaipur, Rajasthan. Education (ASME) | |
| MX2019006086A (es) | Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados. | |
| Butkhot et al. | Properties and safety evaluation of Bacillus velezensis BUU004 as probiotic and biopreservative in seafood products. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20121009 |